MedPath

TO FIND RELATIONSHIP BETWEEN INFERIOR VEIN AND FEMORAL VEIN AND ARTERY IN ASSSESSING THE FLUID STATUS IN CRITICALLY ILL PATIENTS

Recruiting
Conditions
Shock, unspecified,
Registration Number
CTRI/2023/06/053815
Lead Sponsor
DEPARTMENT OF CRITICAL CARE SGPGI
Brief Summary

The objective of this exploratory study is to find out the correlation of femoral vein diameter (FVD)/femoral artery diameter (FAD) with IVC to central venous pressure (CVP) measurements and to help ascertain the fluid volume status in a critically ill patient and to see whether FVD/FAD ratio be alternative to IVC measurement in assessing volume status in critically ill patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
75
Inclusion Criteria

patients over 18 years of age on mechanical ventilation on invasive monitoring.

Exclusion Criteria
    1. Patients with a right atrium dilatation or right ventricle tumour.
    1. Patients with severe stenosis of the pulmonary valve or tricuspid valve 3) Patients with a skin infection at the puncture site 4) Patients with lower extremity artery/vein thrombosis, significant lower extremity artery plaque, lower extremity artery occlusion, inferior vena cava filter implantation, lower extremity varicose veins, or aortic stenosis.
    1. Patients who IVC cannot be visualized.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To find out the correlation of femoral vein diameter & femoral artery diameter with IVC to central venous pressure measurements & to help ascertain the fluid volume status in a critically ill patientfirst 24 hours of admission
Secondary Outcome Measures
NameTimeMethod
no secondary outcomesfirst 24 hours of admission

Trial Locations

Locations (1)

SGPGI

🇮🇳

Lucknow, UTTAR PRADESH, India

SGPGI
🇮🇳Lucknow, UTTAR PRADESH, India
DR AFZAL AZIM
Principal investigator
9984988393
draazim2002@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.